System Uses Surface Electrodes to Monitor Highly Accurate, Non-Invasive Fetal and Maternal Heart Rate and Uterine Contraction
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005118/en/
Henry Schein Medical signs an exclusive distribution and supply agreement for MindChild's MERIDIAN™ M110 Fetal Monitoring System. (Photo: Business Wire)
In a labor and delivery (L&D) setting, the MERIDIAN M110 derives these
vital signs from maternal and fetal electrocardiogram (ECG) and uterine
contraction signals captured via electrodes on the surface of a mother’s
abdomen. These vital signs are then displayed on existing primary fetal
monitors. The MERIDIAN M110 is indicated for use on women who are at ≥37
weeks into their pregnancy, in labor, and is intended for use only by
health care professionals in a clinical setting, such as an
“This is a great milestone for MindChild and Henry Schein and, more
importantly, will result in excellent care to millions of women and
Dr. Wolfberg continued, “In the coming months and years, MindChild will build on this technology to improve the safety of obstetrics, and provide a new diagnostic device to obstetricians and pediatric cardiologists.”
For more information, or to order MindChild products, please contact a Henry Schein sales consultant at (800) 772-4346.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100®
indexes, Henry Schein is headquartered in Melville, N.Y., and has
operations or affiliates in 31 countries. The Company's sales from
continuing operations reached
MindChild was co-founded by
With offices in
About the MERIDIAN M110 Non-Invasive Fetal Heart Rate Monitor
MERIDIAN M110 is a maternal-fetal monitor that non-invasively measures and displays fetal heart rate (FHR), maternal heart rate (MHR) and uterine contractions (UA). MERIDIAN acquires and displays the FHR and MHR from abdominal surface electrodes that detect the fetal ECG signal (fECG), maternal ECG and uterine muscle contraction signals. MERIDIAN M110 is designed for women who are at term (≥ 37 completed weeks), in labor, with singleton pregnancies. MERIDIAN M110 is intended for use only by healthcare professionals in a clinical setting.
About the Fetal Heart Monitoring Market
Over 85%1 of the 4,000,0002 live births in the US
during 2011 required fetal monitoring during labor and delivery. Current
non-invasive Doppler, employing ultrasound to detect FHR is subject to
loss of fetal heart rate due to maternal/fetal movement3.
Fetal Scalp Electrodes (FSE) that connect directly to the fetus during
the later stages of labor and delivery are invasive devices associated
with increased risk of maternal/fetal infection4. There are
an estimated 28,000 fetal monitors spread over 3,400 hospitals in the US5,
representing an investment of over
1 "ACOG Refines Fetal Heart Rate Monitoring Guidelines", 6/22/2009 The American College of Obstetricians and Gynecologists Press Release
|3 Journal of Midwifery. Vol 18, No, 7: 424-428. July 2010|
|4 American Family Physician, 1992 Feb;45(2):579-82|
|6 Company estimates.|
Ann Marie Gothard
Vice President, Corporate Media Relations
Henry Schein, Inc.
Chief Executive Officer
MindChild Medical, Inc.
(978) 975-1160 x213